
ArtificaX Technologies helps biotech teams accelerate research with AI-powered drug discovery and private on-device AI agents. It delivers RapidDrug for target-to-hit compounds in a week and AXAgents that run locally with tool-use capabilities. Core tech includes small language models, on-device privacy-preserving AI, deep learning vision, and large language models. The company operates as a B2B AI software provider for biotech and pharma, with workflows designed to integrate AI-driven target analysis and discovery pipelines. It also offers Draw2Cost for rapid manufacturing cost estimates from 2D drawings, highlighting a broader focus on scaling discovery and reducing development timelines across drug discovery and manufacturing cost estimation.

ArtificaX Technologies helps biotech teams accelerate research with AI-powered drug discovery and private on-device AI agents. It delivers RapidDrug for target-to-hit compounds in a week and AXAgents that run locally with tool-use capabilities. Core tech includes small language models, on-device privacy-preserving AI, deep learning vision, and large language models. The company operates as a B2B AI software provider for biotech and pharma, with workflows designed to integrate AI-driven target analysis and discovery pipelines. It also offers Draw2Cost for rapid manufacturing cost estimates from 2D drawings, highlighting a broader focus on scaling discovery and reducing development timelines across drug discovery and manufacturing cost estimation.